Xiaoyang Xu

Search results

• Research from New Jersey Institute of Technology Broadens Understanding of Pyroptosis (mRNA lipid nanoparticle-mediated pyroptosis sensitizes immunologically cold tumors to checkpoint immunotherapy)

  Xu, X.

  7/28/23

  1 item of Media coverage

  Press/Media: Press / Media

• Studies from New Jersey Institute of Technology Add New Findings in the Area of Gene Therapy (Enzyme-catalyzed One-step Synthesis of Ionizable Cationic Lipids for Lipid Nanoparticle-based Mrna Covid-19 Vaccines)

  Xu, X.

  11/25/22

  1 item of Media coverage

  Press/Media: Press / Media

• NJIT'S XU IS DEVELOPING A TIMED-RELEASE MRNA VACCINE WITH AN EXTENDED SHELF LIFE

  Xu, X.

  8/31/21

  1 item of Media coverage

  Press/Media: Press / Media

• US Patent Issued to THE BRIGHAM AND WOMEN'S HOSPITAL, Massachusetts Institute of Technology on Dec. 29 for "Cationic nanoparticles for co-delivery of nucleic acids and therapeutic agents" (Massachusetts Inventors)

  Xu, X.

  1/4/21

  1 item of Media coverage

  Press/Media: Press / Media

• US Patent Issued to New Jersey Institute of Technology on May 19 for "Photoluminescent hydrogel" (New Jersey Inventors)

  Xu, X.

  5/20/20

  1 item of Media coverage

  Press/Media: Press / Media

• Cranford's Sydney Sweet Wins Prestigious Scholarship

  Xu, X.

  4/23/20

  1 item of Media coverage

  Press/Media: Press / Media

• NJIT 2020 Goldwater Scholar class among largest in US

  Xu, X., Datta, D., Armenante, P., Afkhami, S., Carpinelli, J. & Thomas, B.

  4/22/20

  1 item of Media coverage

  Press/Media: Press / Media

• NJIT 2020 GOLDWATER SCHOLAR CLASS AMONG LARGEST IN U.S.

  Xu, X., Datta, D., Armenante, P., Afkhami, S., Carpinelli, J. & Thomas, B.

  4/16/20

  1 item of Media coverage

  Press/Media: Press / Media